The μ Opioid Receptor and Ligands Acting at the μ Opioid Receptor, as Therapeutics and Potential Therapeutics

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|19|42|7415-7434

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.42, 2013-12, pp. : 7415-7434

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-activity Relationship, Conformation and Pharmacology Studies of Morphiceptin Analogues - Selective μ-Opioid Receptor Ligands

By  

Mini Reviews in Medicinal Chemistry, Vol. 2, Iss. 6, 2002-12 ,pp. : 565-572

Bentham Science Publishers

Access to resources Recommend Favorite

Kappa-opioid receptor ligands

By Husbands Stephen M  

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 12, 2004-12 ,pp. : 1725-1741

Informa Healthcare

Access to resources Recommend Favorite

Nicotinic acetylcholine receptor ligands as potential therapeutics

By Gündisch Daniela  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 9, 2005-09 ,pp. : 1221-1239

Informa Healthcare

Access to resources Recommend Favorite

Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction

By  

Current Drug Abuse Reviews, Vol. 2, Iss. 1, 2009-01 ,pp. : 83-98

Bentham Science Publishers

Access to resources Recommend Favorite

Tapentadol in Pain Management: A μ-Opioid Receptor Agonist and Noradrenaline Reuptake Inhibitor

By Hartrick Craig T.   Rozek Richard J.  

CNS Drugs, Vol. 25, Iss. 5, 2011-05 ,pp. : 359-370

Adis International

Access to resources Recommend Favorite